Udg Healthcare PLC (UDG) Rating Reiterated by N+1 Singer
Udg Healthcare PLC (LON:UDG)‘s stock had its “hold” rating reiterated by stock analysts at N+1 Singer in a research report issued to clients and investors on Tuesday. They presently have a GBX 770 ($10.00) target price on the stock. N+1 Singer’s target price indicates a potential downside of 4.29% from the stock’s current price.
A number of other brokerages have also recently commented on UDG. Jefferies Group LLC restated a “hold” rating and issued a GBX 785 ($10.19) price target on shares of Udg Healthcare PLC in a research report on Thursday, August 3rd. Stifel Nicolaus restated a “hold” rating and issued a GBX 775 ($10.06) price target on shares of Udg Healthcare PLC in a research report on Thursday, August 3rd. Liberum Capital restated a “buy” rating and issued a GBX 930 ($12.07) price target on shares of Udg Healthcare PLC in a research report on Monday, June 19th. Numis Securities Ltd restated a “hold” rating and issued a GBX 730 ($9.48) price target on shares of Udg Healthcare PLC in a research report on Thursday, August 3rd. Finally, Berenberg Bank cut Udg Healthcare PLC to a “hold” rating and set a GBX 745 ($9.67) target price for the company. in a research report on Monday, May 8th. Seven analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of GBX 809.14 ($10.50).
Shares of Udg Healthcare PLC (LON:UDG) opened at 804.50 on Tuesday. The company’s market cap is GBX 1.99 billion. Udg Healthcare PLC has a 12 month low of GBX 596.00 and a 12 month high of GBX 886.50. The stock’s 50 day moving average price is GBX 842.41 and its 200-day moving average price is GBX 761.51.
In related news, insider Chris Corbin sold 5,650 shares of the stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of GBX 827 ($10.74), for a total transaction of £46,725.50 ($60,658.83). Also, insider Jez Moulding bought 18,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 31st. The shares were acquired at an average price of GBX 808 ($10.49) per share, with a total value of £145,440 ($188,809.55).
About Udg Healthcare PLC
UDG Healthcare plc, formerly United Drug plc, is a healthcare services provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The Company operates in three segments. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies.
Receive News & Ratings for Udg Healthcare PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.